BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, March 14, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 14, 2003

View Archived Issues

PPARdelta shown to inhibit cardiac inflammatory responses in vitro and in vivo

Read More

Antiproliferative and differentiation-inducing effects of ratjadone on coronary smooth muscle cells

Read More

Antithrombotic efficacy of the PAR-1 antagonist E-5555 in guinea pigs

Read More

VX-702, a p38 MAPK inhibitor, reduces myocardial ischemia-reperfusion damage in rats

Read More

Amersham inlicenses amyloid-targeting PET agents

Read More

New uroselective alpha1-AR antagonists developed at Ranbaxy

Read More

Esteve scientists claim new NPY Y5 modulators for obesity and other uses

Read More

Pfizer presents two series of PPAR modulators with potential as antidiabetic agents

Read More

Novel estrogen receptor modulators prepared and tested by Wyeth researchers

Read More

CyFi patent covers sodium channel blockers as mucosa protecting agents

Read More

Lilly presents new factor Xa inhibitors

Read More

Orchid scientists present new COX-2/COX-3 inhibitors

Read More

New 5-HT1F agonists and their use in migraine therapy reported by Lilly

Read More

MRA potentially effective for adult rheumatoid arthritis

Read More

ICN becomes Valeant Pharmaceuticals International

Read More

Two additional pivotal trials for IGN-101

Read More

MK-0869 phase III program discontinued

Read More

New safety trial for HCV drug R-803

Read More

Preliminary phase Ib results support antiretroviral activity of TNX-355 for HIV

Read More

AIDSVAX B/E fails to meet endpoints in phase III HIV trial

Read More

Nitrate ester from GBTherapeutics improves cognition in rat model

Read More

YM BioSciences and Oncoscience sign licensing agreement for TheraCIM hR3

Read More

Erythropoietin and analogue AA-18231 afford significant neuroprotection in hypoxia-ischemia

Read More

Inhibition of glutamate carboxypeptidase II as a novel approach to diabetic retinopathy

Read More

Neuroprotective and antiinflammatory effects established for GLI-7501

Read More

Potent, rapid-acting antidepressant emerges from major Lundbeck program

Read More

Human central nervous system stem cell grafts improve recovery in SCI model

Read More

Human embryonic stem cell-derived oligodendrocyte progenitors: a promising approach to SCI

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 13, 2026.
  • Tanycytes in green capturing tau protein in red.

    Brain’s hidden tau-clearing pathway uncovered

    BioWorld Science
    Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 10, 2026
  • MSD synthesizes α-synuclein PET agents

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
  • Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent

    BioWorld Science
    Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing